CHICAGO--Meitheal Pharmaceuticals, Inc. ("Meitheal"), a fully integrated biopharmaceutical company headquartered in Chicago ...

GoodRx reports that once-a-week insulin, such as Awiqli, offers a convenient option for Type 2 diabetes management, ...

Awiqli is the world's first once-a-week basal insulin injection ...

Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the treatment of type 1 and type 2 diabetes in adults ...

Add Yahoo as a preferred source to see more of our stories on Google. Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for eligible adults with diabetes. Experts explain how it works, who may ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may now need just one injection a week.

June 25 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign ...

When I was first diagnosed with diabetes, I felt ashamed. I didn't tell anyone for a while and didn't identify as diabetic internally, either. But eventually, I accepted my diagnosis, and doing my ...

A 40-year-old woman with type 1 diabetes mellitus (T1DM) who injected insulin into her abdomen developed a firm subcutaneous mass in the right lower quadrant. Pathology after surgical excision showed ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...